User:Marykuramoto/sandbox

Medpace

Medpace is a global full-service Contract Research Organization providing Phase I-IV core development services for drug, biologic, and medical device device programs. Medpace has 1300 employees and clinical trial experience in over 40 countries, In addition to Phase II-IV development services, Medpace provides Phase I-IIA services from Medpace Clinical Pharmacology, central laboratory and therapeutically specialized testing from Medpace Reference Laboratories, complete bioanalytical services in all stages of drug development from Medpace Bioanalytical Laboratories, centralized imaging core laboratory management and reading from Medpace Imaging Core Laboratory, and medical device development from Medpace Medical Device.

CROs are partners to drug developers in the pharmaceutical and biotech industries, conducting clinical trials that are required by the FDA and other global regulatory organizations before drugs and medical devices are approved for market. CROs were developed in the late 70s as a response to pharmaceutical companies’ needs for strategic outsourcing partners to handle larger and more complex clinical studies.

Medpace History

Medpace was founded in 1992 in Cincinnati, Ohio by Dr. August Troendle with several partners. Dr. Troendle first became interested in the CRO sector after working in both the regulatory and pharmaceutical arena. He began his career specializing in the development of lipid lowering therapies to treat high cholesterol. As a reviewer with the FDA and then a major pharmaceutical company - he became convinced that a better solution for drug developers could be found by placing regulatory and medical expertise into the clinical trial process at the beginning of the clinical trial. Most recently Medpace celebrated 20 years as a CRO and built a new research campus in Madisonville, a village within Cincinnati and is an industry in the life sciences arena.

Medpace Timeline


 * 1992-Medpace established as Medical Research Services (MRS)
 * 1997-MRS becomes an independent company
 * 2000-Company name is changed to Medpace
 * 2003-Medpace establishes Imagepace, now known as Medpace Imaging Core Lab (ICL)
 * 2005-Medpace opens office in Germany
 * 2006-Medpace establishes offices in Belgium, Brazil, Israel, Netherlands, and South Africa.
 * 2006-Medpace establishes Medpace Reference Laboratories (MRL), central lab
 * 2007-Medpace adds offices in Australia, China, Czech Republic, India, and Singapore
 * 2008-Medpace opens Medpace Bioanalytical Laboratory, Medpace Clinical Pharmacology
 * 2008-Medpace opens offices in Hong King and the UK
 * 2009-Medpace adds offices in Russia, opens MRL locations in India and China
 * 2009-Medpace acquires PharmaBrains AG, establishing an office in Switzerland
 * 2010-Medpace acquires Symbios, and Medical Consulting Dr. Schlichtiger, Gmbh, in Munich.
 * 2010-Medpace completes a new research campus in Madisonville, a village within the City of Cincinnati limits
 * 2011-Medpace enters into an agreement with CCMP Capital Advisors and adds offices in Scotland and Italy
 * 2012-Medpace acquires MediTech-NL, a medical device consultancy and adds an office in France

Medpace Services and Therapeutic Specialties

Medpace works with pharmaceutical and medical device companies to conduct clinical trials for the purpose of bringing new drugs and medical devices to the approval process with the necessary regulatory authorities. Medpace conducts studies in metabolism, cardiology, oncology, neuroscience, infectious disease, nephrology, regenerative medicine, and gastrointestinal areas.


 * Clinical Operations
 * Medical Writing
 * Biometrics
 * Regulatory Affairs
 * Quality Assurance
 * Pharmacovigilance
 * Central Laboratories
 * Imaging Core Laboratories
 * Bioanalytical Laboratories
 * Clinical Pharmacology
 * Late Phase

Medpace Awards

Medpace has received multiple awards from investigator sites in recent years, including Top CRO in the 2009 CenterWatch Site Survey, the highest score for speed of site recruitment from the ISR Reports, 2011 CRO Quality Benchmarking Report, and the 2011 and 2012 Site Solutions Summit Eagle Award.